Steve Gullans

Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Catch.com was a personal content management system with mobile and online applications designed to make it easy to capture, organize and sync ideas, notes, places, images, sounds, and other private information. It aimed to be the 'private feed' and first draft for personal content by offering strong security standards and clear sharing options to popular services. Based in San Francisco, it has become one of the leading developers in the Android Market with active installs with an open API and Android Intents for third-party developers.

Activate Networks, Inc. provides technology for analyzing real life social networks of physicians and patients. Its services include social network analysis, organizational network analysis, influence marketing and organizational effectiveness. The firm has locations in New York and San Francisco. The company was founded by Nicholas Christakis, Peter DeWan, Gerald J. Gallivan and Lawrence G. Miller in 2009 and is headquartered in Newton, MA.

BIOCIUS Life Sciences, Inc. provides medical laboratory services. The company was founded in 2009 and is headquartered in Wakefield, MA.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH.

Navigation Sciences, Inc. is a private company that specializes in developing the NaviSci™ system, which provides real-time margin measurement for precision cancer surgery. The company is based in Brookline, MA. The system is designed to address the growing need to locate and remove lung and other soft tissue cancers. The company was founded in 2017 by Jayender Jagadeesan, Alan D. Lucas, and Raphael Bueno. Alan D. Lucas has been the CEO since 2017.

Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The private company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015.

Metis Minds, Inc. is a company that offers a digital curriculum called Skylar's Run, which is a video game designed to enhance children's cognitive abilities, including attention, impulse control, and self-regulation. The company is based in Orlando, FL. The game measures and adapts to the child's attention levels, offering a personalized level of challenge. The company was founded by Steven R. Gullans and Barry K. Herman, and Steven R. Gullans has been the CEO since incorporation.